SEROXAT

This brand name is authorized in Austria, Cyprus, Germany, Estonia, Spain, Finland, Hong Kong, Croatia, Ireland, Israel, Italy, Lithuania, Malta, Netherlands, Poland, Romania, Singapore, United Kingdom

Active ingredients

The drug SEROXAT contains one active pharmaceutical ingredient (API):

1 Paroxetine UNII 3I3T11UD2S - PAROXETINE HYDROCHLORIDE ANHYDROUS

Paroxetine is a potent and selective inhibitor of 5-hydroxytryptamine (5-HT, serotonin) uptake and its antidepressant action and effectiveness in the treatment of OCD, Social Anxiety disorder/Social Phobia, General Anxiety Disorder, Post-Traumatic Stress Disorder and Panic Disorder is thought to be related to its specific inhibition of 5-HT uptake in brain neurones. Read about Paroxetine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
SEROXAT Film-coated tablet / Oral suspension	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N06AB05	Paroxetine	N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AB Selective serotonin reuptake inhibitors
Discover more medicines within N06AB05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00191690, 00191709, 00221221, 00614475, 00614481, 00614498, 10273093, 11229473
Country: EE	Ravimiamet	Identifier(s): 1027044, 1060221, 1060232, 1060243, 1304334, 1855054, 1855144, 1855155
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 59468
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 038257, 038448
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 112707, 140011, 162434, 162436, 162438, 175954, 186127, 19311, 19312, 21579, 375966
Country: HK	Department of Health Drug Office	Identifier(s): 51959, 51960, 64700
Country: IE	Health Products Regulatory Authority	Identifier(s): 45206, 45241, 45268, 45285, 45601, 45608, 45609, 45691
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 2892
Country: IT	Agenzia del Farmaco	Identifier(s): 027963038
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1003159, 1003732, 1021137, 1023776, 1023777, 1023778, 1023779, 1023780, 1023781, 1023782, 1023783, 1023784, 1023785, 1023786, 1023806, 1023808, 1023809, 1024257, 1024258, 1034677, 1057990, 1057991, 1057992, 1057993, 1057994, 1057995, 1057996, 1057997, 1057998, 1057999, 1058000, 1058001, 1058002, 1058003, 1058004, 1058005, 1058006, 1058007, 1082801
Country: MT	Medicines Authority	Identifier(s): MA192/02501, PI908/01101A
Country: NL	Z-Index G-Standaard	Identifier(s): 14558785
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 125032, 125059, 56154
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100060832, 100255961, 100283779, 100285689, 100333543, 100360570, 100366778, 100370461, 100377115, 100399460, 100424961, 100431903, 100460562
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W65203001, W65203003
Country: SG	Health Sciences Authority	Identifier(s): 07053P, 12583P, 12584P